The American Healthcare Conundrum (github.com)

Article summary

The US healthcare system spends significantly more per person than other countries, with an estimated $3.24 trillion in annual waste. A project analyzing healthcare data has identified specific issues, such as the 340B Drug Pricing Program, that contribute to this waste. The project aims to quantify the waste and recommend policy fixes. The analysis uses open-source code and primary federal data to estimate the waste and potential savings.

Main themes

• healthcare costs
• pricing power
• cross-subsidization
• Affordable Care Act
• price caps
• misaligned incentives
• healthcare reform
• international perspective
• pharmaceutical pricing
• hospital pricing
• insurance industry
• socialized health plan
• inefficient system
• unfair system
• equitable system
• transparent system
• rationing of care
• shortages
• regulatory capture
• licensing
• market manipulations
• single payer
• free market rate
• national healthcare systems
• medical tourism
• MRI scans
• joint replacement surgery
• electric utilities
• natural monopolies
• price regulation
• monopolies
• supply and demand curves
• blackouts
• unplanned surge in demand
• gas lines
• electricity shortages
• pipelines
• railroads
• federal regulation
• state regulation
• market failure
• baseline diagnostic tool
• diagnostic tool
• per capita
• insane figure
• fortune
• nvidia
• hometown
• santa clara
• Micro supply and demand curves
• Micro
• supply
• demand
• curves

What commenters say

• The high cost of healthcare in the US is driven by a complex system of incentives and pricing power, rather than just cross-subsidization of Medicare by commercial insurers.
• The Affordable Care Act has been subverted by the medical lobby and has failed to control costs, leading to a system that is inefficient and unfair.
• Price caps on healthcare providers and pharmaceuticals could help control costs, but may also lead to shortages and rationing of care.
• The US healthcare system is characterized by misaligned incentives, with insurance companies prioritizing profits over patient care, and hospitals charging wildly different prices for equivalent services.
• The cross-subsidy argument is used by hospitals to justify high commercial rates, but data suggests that this is not the full story, and pricing power in a concentrated market plays a significant role.
• The solution to the healthcare crisis lies in a more fundamental reform of the system, rather than just tweaking the current structure.
• The international perspective suggests that the high price of drugs in the US is the driving force in drug research, and that other countries may be subsidized by the US system.
• The current system is not insurance, but rather a socialized health plan that is inefficient and unfair, and a better approach would be to have a more transparent and equitable system.